These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 19686722)

  • 1. The xenon-mediated antagonism against the NMDA receptor is non-selective for receptors containing either NR2A or NR2B subunits in the mouse amygdala.
    Haseneder R; Kratzer S; Kochs E; Höfelmann D; Auberson Y; Eder M; Rammes G
    Eur J Pharmacol; 2009 Oct; 619(1-3):33-7. PubMed ID: 19686722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Equilibrium constants for (R)-[(S)-1-(4-bromo-phenyl)-ethylamino]-(2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-methyl]-phosphonic acid (NVP-AAM077) acting at recombinant NR1/NR2A and NR1/NR2B N-methyl-D-aspartate receptors: Implications for studies of synaptic transmission.
    Frizelle PA; Chen PE; Wyllie DJ
    Mol Pharmacol; 2006 Sep; 70(3):1022-32. PubMed ID: 16778008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xenon reduces N-methyl-D-aspartate and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor-mediated synaptic transmission in the amygdala.
    Haseneder R; Kratzer S; Kochs E; Eckle VS; Zieglgänsberger W; Rammes G
    Anesthesiology; 2008 Dec; 109(6):998-1006. PubMed ID: 19034096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NR2A and NR2B subunit containing NMDA receptors differentially regulate striatal output pathways.
    Fantin M; Marti M; Auberson YP; Morari M
    J Neurochem; 2007 Dec; 103(6):2200-11. PubMed ID: 17986236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term potentiation in the nucleus accumbens requires both NR2A- and NR2B-containing N-methyl-D-aspartate receptors.
    Schotanus SM; Chergui K
    Eur J Neurosci; 2008 Apr; 27(8):1957-64. PubMed ID: 18412616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Native N-methyl-D-aspartate receptors containing NR2A and NR2B subunits have pharmacologically distinct competitive antagonist binding sites.
    Christie JM; Jane DE; Monaghan DT
    J Pharmacol Exp Ther; 2000 Mar; 292(3):1169-74. PubMed ID: 10688637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that Xenon does not produce open channel blockade of the NMDA receptor.
    Weigt HU; Adolph O; Georgieff M; Georgieff EM; Föhr KJ
    J Neurophysiol; 2008 Apr; 99(4):1983-7. PubMed ID: 18234987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological properties of recombinant human N-methyl-D-aspartate receptors comprising NR1a/NR2A and NR1a/NR2B subunit assemblies expressed in permanently transfected mouse fibroblast cells.
    Priestley T; Laughton P; Myers J; Le Bourdellés B; Kerby J; Whiting PJ
    Mol Pharmacol; 1995 Nov; 48(5):841-8. PubMed ID: 7476914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substitution for PCP, disruption of prepulse inhibition and hyperactivity induced by N-methyl-D-aspartate receptor antagonists: preferential involvement of the NR2B rather than NR2A subunit.
    Chaperon F; Müller W; Auberson YP; Tricklebank MD; Neijt HC
    Behav Pharmacol; 2003 Sep; 14(5-6):477-87. PubMed ID: 14501261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xenon attenuates excitatory synaptic transmission in the rodent prefrontal cortex and spinal cord dorsal horn.
    Haseneder R; Kratzer S; Kochs E; Mattusch C; Eder M; Rammes G
    Anesthesiology; 2009 Dec; 111(6):1297-307. PubMed ID: 19934875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and subunit composition of synaptic NMDA receptors in the amygdala: NR2B synapses in the adult central amygdala.
    Lopez de Armentia M; Sah P
    J Neurosci; 2003 Jul; 23(17):6876-83. PubMed ID: 12890782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. State-dependent NMDA receptor antagonism by Ro 8-4304, a novel NR2B selective, non-competitive, voltage-independent antagonist.
    Kew JN; Trube G; Kemp JA
    Br J Pharmacol; 1998 Feb; 123(3):463-72. PubMed ID: 9504387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NR2A-containing NMDA receptors depress glutamatergic synaptic transmission and evoked-dopamine release in the mouse striatum.
    Schotanus SM; Chergui K
    J Neurochem; 2008 Aug; 106(4):1758-65. PubMed ID: 18540994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol.
    Ilyin VI; Whittemore ER; Guastella J; Weber E; Woodward RM
    Mol Pharmacol; 1996 Dec; 50(6):1541-50. PubMed ID: 8967976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The NR2B-selective N-methyl-D-aspartate receptor antagonist Ro 25-6981 [(+/-)-(R*,S*)-alpha-(4-hydroxyphenyl)-beta-methyl-4-(phenylmethyl)-1-piperidine propanol] potentiates the effect of nicotine on locomotor activity and dopamine release in the nucleus accumbens.
    Kosowski AR; Liljequist S
    J Pharmacol Exp Ther; 2004 Nov; 311(2):560-7. PubMed ID: 15256539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A critical role of the N-methyl-D-aspartate (NMDA) receptor subunit (NR) 2A in the expression of redox sensitivity of NR1/NR2A recombinant NMDA receptors.
    Brimecombe JC; Potthoff WK; Aizenman E
    J Pharmacol Exp Ther; 1999 Nov; 291(2):785-92. PubMed ID: 10525101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conditioning-strength dependent involvement of NMDA NR2B subtype receptor in the basolateral nucleus of amygdala in acquisition of auditory fear memory.
    Zhang XH; Liu F; Chen Q; Zhang CL; Zhuo M; Xiong ZQ; Li BM
    Neuropharmacology; 2008 Aug; 55(2):238-46. PubMed ID: 18573264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological and genetic evidence indicates that combined inhibition of NR2A and NR2B subunit containing NMDA receptors is required to disrupt prepulse inhibition.
    Spooren W; Mombereau C; Maco M; Gill R; Kemp JA; Ozmen L; Nakanishi S; Higgins GA
    Psychopharmacology (Berl); 2004 Aug; 175(1):99-105. PubMed ID: 14985927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of the C-terminal domain of the NR2B subunit alters channel properties and synaptic targeting of N-methyl-D-aspartate receptors in nascent neocortical synapses.
    Mohrmann R; Köhr G; Hatt H; Sprengel R; Gottmann K
    J Neurosci Res; 2002 May; 68(3):265-75. PubMed ID: 12111856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synaptic and extrasynaptic NMDA receptor NR2 subunits in cultured hippocampal neurons.
    Thomas CG; Miller AJ; Westbrook GL
    J Neurophysiol; 2006 Mar; 95(3):1727-34. PubMed ID: 16319212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.